SURMOUNT-1 published in the New England Journal of Medicine in July 2022, showing 22.5% weight loss at 72 weeks (Jastreboff et al., NEJM 2022)
Staying Ahead of the Change The companies and brands that innovate in anticipation of the impact of these drugs will find themselves awash in new interest from those who feel a new sense of control and autonomy in their choices: brands that speak to their aspirational selves, affirm their commitments to living better, and underscore that behavior-modifying medications are only step one of a lifelong shift that includes their category and brand
Progressive Overload The gradual increase of stress placed on the body during exercise, typically achieved by increasing weight, reps, or training volume over time
What Drives Costs Beyond Just Medication Many patients dont realize that the medicine itself isnt the only thing they pay for
I think Retatrutide has unique potential for women approaching pregnancy in the 6-18 month timeframe
Of interest, Ex4 was effective in both inhibiting proliferation, migration, and invasion of ovarian cancer cells and enhancing their apoptosis through the inhibition of the PI3K/Akt pathway